Tag: FDA inspections
Chinese Generic Production: Manufacturing and Quality Concerns
China supplies 80% of global API, raising quality and supply chain concerns. Explore FDA inspection gaps, purity issues, and the push for diversification in 2026.
Quality concerns: when clinicians question generic manufacturing
Clinicians are raising alarms about the quality of generic drugs made overseas, especially in India and China. Studies show higher rates of adverse events, supply chain risks, and inspection gaps-raising urgent questions about safety, transparency, and the future of affordable medicine.